138.00
price down icon0.65%   -0.90
after-market After Hours: 138.00
loading
Natera Inc stock is traded at $138.00, with a volume of 1.73M. It is down -0.65% in the last 24 hours and down -17.84% over the past month. Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$138.90
Open:
$139.4
24h Volume:
1.73M
Relative Volume:
1.35
Market Cap:
$18.84B
Revenue:
$1.53B
Net Income/Loss:
$-214.69M
P/E Ratio:
-78.41
EPS:
-1.76
Net Cash Flow:
$-43.68M
1W Performance:
-1.87%
1M Performance:
-17.84%
6M Performance:
-17.90%
1Y Performance:
+34.41%
1-Day Range:
Value
$137.90
$141.20
1-Week Range:
Value
$136.91
$143.36
52-Week Range:
Value
$92.14
$183.00

Natera Inc Stock (NTRA) Company Profile

Name
Name
Natera Inc
Name
Phone
650-249-9090
Name
Address
13011 MCCALLEN PASS, AUSTIN, CA
Name
Employee
4,434
Name
Twitter
@nateragenetics
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
NTRA's Discussions on Twitter

Compare NTRA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
NTRA
Natera Inc
138.00 18.97B 1.53B -214.69M -43.68M -1.76
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
484.96 180.56B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
202.94 147.13B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
566.50 45.45B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
119.54 34.14B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
197.76 33.86B 15.50B 1.33B 2.16B 7.34

Natera Inc Stock (NTRA) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-13-25 Initiated RBC Capital Mkts Outperform
Jan-23-25 Initiated Barclays Overweight
Jun-03-24 Resumed Jefferies Buy
Apr-08-24 Resumed Craig Hallum Buy
Feb-20-24 Downgrade Raymond James Strong Buy → Outperform
Dec-29-23 Reiterated BTIG Research Buy
Dec-14-23 Initiated Guggenheim Buy
Dec-13-23 Initiated Wolfe Research Outperform
Nov-13-23 Upgrade Raymond James Outperform → Strong Buy
Sep-28-23 Initiated Bernstein Mkt Perform
Jul-05-23 Resumed JP Morgan Overweight
May-05-23 Initiated UBS Buy
Jan-18-23 Upgrade Raymond James Mkt Perform → Outperform
Aug-25-22 Initiated Credit Suisse Outperform
Apr-25-22 Initiated Stephens Overweight
Mar-08-22 Initiated Goldman Buy
Jan-06-22 Resumed Piper Sandler Overweight
Oct-15-21 Resumed Cowen Outperform
Jun-15-21 Initiated Raymond James Mkt Perform
May-25-21 Initiated Wells Fargo Overweight
Jan-28-21 Initiated Truist Buy
Oct-08-20 Initiated BTIG Research Buy
Sep-28-20 Initiated Morgan Stanley Overweight
Sep-17-20 Initiated SVB Leerink Outperform
Jun-10-20 Resumed Piper Sandler Overweight
May-07-20 Upgrade JP Morgan Neutral → Overweight
Oct-05-18 Initiated JP Morgan Neutral
Jul-05-18 Reiterated Piper Jaffray Overweight
Aug-07-17 Reiterated Morgan Stanley Overweight
Nov-10-16 Reiterated The Benchmark Company Buy
May-23-16 Reiterated The Benchmark Company Buy
May-11-16 Reiterated The Benchmark Company Buy
Apr-19-16 Initiated The Benchmark Company Buy
Sep-28-15 Upgrade Wedbush Neutral → Outperform
Aug-14-15 Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-04-15 Initiated Robert W. Baird Outperform
Jul-27-15 Initiated Morgan Stanley Equal-Weight
Jul-27-15 Initiated Piper Jaffray Overweight
Jul-27-15 Initiated Wedbush Neutral
View All

Natera Inc Stock (NTRA) Latest News

pulisher
Jul 28, 2025

NeoGenomics Wants Jury Trial In Natera DNA Test Patent Fight - Law360

Jul 28, 2025
pulisher
Jul 28, 2025

Judge trims Natera verdict, keeps ad ban and bulk of damages - Daily Journal

Jul 28, 2025
pulisher
Jul 28, 2025

Evercore ISI initiates Natera stock with Outperform rating, $170 price target - Investing.com Australia

Jul 28, 2025
pulisher
Jul 28, 2025

Non-Invasive Prenatal Testing Market Forecast and Company - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

Non-Invasive Prenatal Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Natera Inc. stockCapitalize on market trends before they peak - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Genetic testing company opens patient service center in Cumberland County - PennLive.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Natera Inc. stockDiscover stocks with explosive growth potential - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How strong is Natera Inc. company’s balance sheetMaximize your portfolio’s growth with expert tips - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What markets is Natera Inc. expanding into Is ATYR stock a good long term investment optionChart Pattern Recommendation For Smart Trading - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does Natera Inc. compare to its industry peersHigh-yield portfolio picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Natera Inc. stock price move sharplyProven Return Strategy Execution - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 21:21:41 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Natera Inc. stock expected to show significant growthRapid wealth creation - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are Natera Inc. company’s key revenue driversTremendous return rates - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

Natera Maintains Strong Buy Rating from Leerink Partners Amid Insider Selling - AInvest

Jul 26, 2025
pulisher
Jul 25, 2025

RBC Capital Maintains a Buy on Natera (NTRA) With a $251 PT - Insider Monkey

Jul 25, 2025
pulisher
Jul 25, 2025

10 Best Strong Buy Healthcare Stocks to Buy Now - Insider Monkey

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Natera Inc. stockTriple-digit growth rates - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth - GlobeNewswire Inc.

Jul 25, 2025
pulisher
Jul 25, 2025

What institutions are buying Natera Inc. stock nowHigh-yield capital appreciation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Natera CFO Brophy sold $303k in NTRA stock - Investing.com Australia

Jul 24, 2025
pulisher
Jul 24, 2025

Natera CFO Brophy sold $303k in NTRA stock By Investing.com - Investing.com Nigeria

Jul 24, 2025
pulisher
Jul 24, 2025

Natera's Prospera™ Heart with DQS: A Game-Changer in Transplant Monitoring - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

PEDAL Study Successful, Shows Monitoring with Prospera™ Kidney Provides Accurate Prognosis of Long-Term Clinical Outcomes Following Rejection; Now Published in AJT - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

Natera(NTRA) Plunges 1.50% Amid Insider Sales - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Natera's Trading Volume Surges 62.2% to $257 Million, Ranks 440th Despite Stock Price Decline - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Natera Inc. Stock Analysis and ForecastFree Stock Movement Tracking - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

SEC Filings Archive 2025-07-22Historical 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Natera CEO Chapman sells $225,928 in shares By Investing.com - Investing.com India

Jul 22, 2025
pulisher
Jul 22, 2025

Natera’s chief legal officer sells $3.4 million in stock - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

Natera CFO Brophy sold $83,852 in NTRA stock - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

Natera CEO Chapman sells $225,928 in shares - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

Natera president Fesko sells $273k in stock By Investing.com - Investing.com South Africa

Jul 22, 2025
pulisher
Jul 22, 2025

Natera director Sheena Jonathan sells $12953 in shares - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

Natera president Fesko sells $273k in stock - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

Natera Inc: President Moshkevich sells $299k in shares - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

Natera director Sheena Jonathan sells $12953 in shares By Investing.com - Investing.com UK

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Natera Inc. stock priceMarket-beating returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Natera Inc. a good long term investmentMassive portfolio appreciation - jammulinksnews.com

Jul 22, 2025

Natera Inc Stock (NTRA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research DGX
$167.85
price down icon 0.42%
diagnostics_research WAT
$302.36
price down icon 0.19%
diagnostics_research LH
$261.88
price down icon 1.16%
diagnostics_research MTD
$1,261.03
price down icon 0.23%
diagnostics_research IQV
$197.76
price down icon 0.71%
Cap:     |  Volume (24h):